Delivery Order SPE2DB24D1007-SPE2DB25FCACK

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,046.54 firm fixed-price delivery order is for the supply of Focalin XR 5 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of October 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $4,186.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Focalin XR 5 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Firm Fixed Price Delivery Order, with a period of performance running through February 14, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with the ID SPE2DB25D7056|SPE2DB25FTLVJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $2,692.47 firm-fixed-price delivery order is for the supply of 4566921649 Focalin XR 5 mg capsules, a medication used to treat attention-deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. AmerisourceBergen Drug Corp is a major...
This federal contract award, valued at $3,152.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Focalin XR 25 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a period of performance ending on November 30, 2023. This award is not designated as a set-aside...
This federal contract award, valued at $2,871.35, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Focalin XR capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,715.18 firm fixed-price delivery order is for the supply of Focalin XR 10 mg capsules, a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of December 7, 2023 and was awarded on December 6, 2022. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,494.81, is for the delivery of Focalin XR Capsules 10mg, a prescription drug used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract has a completion date of January 28, 2025 and uses a Firm Fixed Price pricing type. This award...
This federal contract award, with ID SPE2DB20D2001|SPE2DB23FM43N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,803.42, is for the delivery of Focalin XR 20 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a firm fixed-price pricing type and an ultimate completion date of March 6, 2023. This contract award is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Focalin XR capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD), with a ceiling value of $1,662.38 and a period of performance through January 24, 2025. The contract is a Firm Fixed Price (FFP) type and does not have a set-aside...
This federal contract award, with ID SPE2DX22D0010|SPE2D825FDM02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,894.74 Firm Fixed Price Delivery Order contract is for the supply of Focalin XR Capsules 10mg, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of February 13, 2025 and was awarded...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FCACK
    Delivery Order

This federal contract award, with the ID SPE2DB24D1007|SPE2DB25FCACK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Focalin XR 5 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD).

The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has a ceiling value of $1,019.56. The ultimate completion date for the contract is February 3, 2025. The contract is not associated with any set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds significant Indefinite Delivery Contracts (IDCs) with the DLA, valued at $999,999,999 through November 2026, and the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/2/25, 9:42 AM